Part 3 Transitional provision in respect of conversion of EU marketing authorisations in force immediately before IP completion dayF1
- 6Conversion of EU marketing authorisations in force before IP completion day
- 7Classification of converted EU marketing authorisations
- 8Obligations of licensing authority in connection with converted EU marketing authorisations
- 9Obligations of holders of converted EU marketing authorisations
- 10Powers of licensing authority in connection with provision of information
- 11Variations of converted EU marketing authorisations notified or applied for before IP completion day
- 12Variations of converted EU marketing authorisations submitted to EMA after IP completion day but before the data submission date
- 13Variations of converted EU marketing authorisations sought in advance of the data submission date
- 14Applications for renewals of converted EU marketing authorisations made before IP completion day
- 15Applications for renewals of conditional marketing authorisations made before IP completion day
- 16Applications for renewals of converted EU marketing authorisations made after IP completion day
- 17Applications for renewals of conditional marketing authorisations made after IP completion day
- 18Renewals of converted EU marketing authorisations sought in advance of the data submission date
- 19Article 61(3) notifications made before IP completion day in relation to converted EU marketing authorisations
- 20Article 61(3) notifications made in relation to converted EU marketing authorisations after IP completion day but before the data submission date
- 21Article 61(3) notifications sought in advance of the data submission date
- 22Place of establishment for converted EU marketing authorisation holder established in EEA state before IP completion day
- 23Temporary exemption as to packaging requirements for converted EU marketing authorisations
- 24Referrals made under Article 20 of Regulation (EC) No 726/2004 that have not concluded or been implemented before IP completion day
- 25Enforcement
Annotations
Textual amendments
- F1
Sch. 33A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 7 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 193); 2020 c. 1, Sch. 5 para. 1(1)